The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Denyer, John ^a   Dyche, Tony ^a  

^a Respiratory Drug Delivery UK Ltd   (United Kingdom)

Author keywords

AAD; Adaptive aerosol delivery system; Adaptive aerosol delivery technology; I neb AAD system; I neb insight; Patient logging system

Indexed keywords

ADAPTIVE AEROSOL DELIVERY; AEROSOL; ALGORITHM; BREATHING MECHANICS; BREATHING PATTERN; DRUG DELIVERY SYSTEM; EXHALATION; FEEDBACK SYSTEM; HUMAN; INSPIRATORY CAPACITY; LUNG DEPOSIT; MEDICAL TECHNOLOGY; REVIEW; TARGET INHALATION MODE; TIDAL BREATHING MODE; UPPER RESPIRATORY TRACT;

ADMINISTRATION, INHALATION; AEROSOLS; ALGORITHMS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS; RESPIRATORY MECHANICS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 77950606953     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0791     Document Type: Review

References (21)

1. Anderson PJ: History of aerosol therapy: liquid nebulization to MDIs and DPIs. Respir Care. 2005;50:1139-1149.
2. Geller D: The science of aerosol delivery in cystic fibrosis. Pediatr Pulmonol. 2008;43:S5-S17.
3. Denyer J, Nikander K, and Smith NJ: Adaptive Aerosol Delivery (AAD) technology. Expert Opin Drug Deliv. 2004;1:165-176.
4. Hess, D: Aerosol delivery devices in the treatment of asthma. Respir Care. 2008;53:699-723.
5. Nikander K, and Denyer J: Adaptive Aerosol Delivery (AAD) Technology. In: Rathbone MJ (ed). Modified Release Drug Delivery Technology, 2nd ed. Informa Healthcare USA, Inc., New York, NY; pp. 603-612, 2008.
6. McCormack P, McDonald A, and Southern KW: Establishing paediatric patients on an Adaptive Aerosol Delivery (AAD) device. J Cyst Fibros. 2006;5(Suppl 1):S76.
7. Potter R, Prince I, Dyche T, Hatley RHM, Smith N: Consistent drug delivery into eight breathing patterns using a prototype I-neb adaptive aerosol delivery (AAD) device-an in vitro study. J Aerosol Med. 2005;18:112-113.
8. Nikander K, Prince I, Coughlin S, Warren S, and Taylor G: Mode of breathing-tidal or slow and deep-through the Ineb Adaptive Aerosol Delivery (AAD) System affects lung deposition of 99mTc-DTPA. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1)S37-S44.
9. Sanders CE, and Milsom WK: The effects of tonic lung inflation on ventilation in the American bullfrog Rana Catesbeiana Shaw. J Exp Biol. 2001;204:2647-2656.
10. Denyer J, Prince I, Dixon E, Agent P, Pryor J, Hodson M: Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S29-S36.
11. Denyer J, Black A, Nikander K, Dyche T, and Prince I: Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S45-S54.
12. Goodman N, Morgan M, Nikander K, Hinch S, and Coughlin S: Evaluation of patient-reported outcomes and quality of life with the I-neb AAD System in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S61-S70.
13. Hardaker LEA, and Hatley RHM: In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) System. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S11-S20.
14. Nikander K, Arheden L, Denyer J, and Cobos N: Parents' adherence with nebulizer treatment of their children when using an Adaptive Aerosol Delivery (AAD) System. J Aerosol Med. 2003;16:273-281.
15. Denyer J, and Dyche T: Patient compliance with inhaled treatment using a novel aerosol delivery system. Eur Respir J. 1998;12(S28):P0647.
16. Everard ML, Ritson S, Denyer J: Aerosol delivery systems acceptable to young children improve drug delivery. Drug Deliv Lungs IV;1998:P120.
17. Conway S, Dodd M, Marsden R, Paul E, and Weller P: Comparison of compliance in cystic fibrosis patients using either a Halolite Adaptive Aerosol Delivery (AAD) system or a conventional high output nebuliser system. J Cyst Fibros. 2002;1(Suppl 1):S67.
18. Nikander K, Denyer J, Dodd M, Dyche T, Webb K, Weller P, and Stableforth D: The Adaptive Aerosol Delivery System in a telehealth setting: patient acceptance, performance, and feasibility. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S21-S28.
19. Dyche T, Prince IR, and Nikander K: Use of I-neb AAD patient logging system data to identify aerosol treatment issues in patients with cystic fibrosis. Am J Respir Crit Care Med. 2007;175;A782.
20. Latchford G, Duff A, Quinn J, Conway S, and Conner M: Adherence to nebulised antibiotics in cystic fibrosis. Patient Ed Counsel. 2009;75:141-144.
21. McNamara P, McCormack P, McDonald AJ, Heaf L, and Southern KW: Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cystic Fibros. 2009;8:258-263